Fortis Healthcare Live BSE/NSE | Fortis Healthcare Fundamenta data | Fortis Healthcare Balance sheet | Fortis Healthcare Quarterly Results | Fortis Healthcare Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

9,489.82
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

10,577.85
N/A
1.47

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.97
1.98
0.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.12
24.47
17.42

PAT CAGR (%)

10 Years
5 Years
3 Years

-10.04
-
-

P:E (Median)

8 Years
5 Years
3 Years

6.10
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.57
1.70
1.55

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.71
25.97
27.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 101 179 -44% 168 168 0% 174 170 2% 181 163 12%
Expenses 111 157 -29% 160 215 -26% 161 204 -21% 156 184 -15%
EBITDA -11 22 - 8 -47 - 13 -34 - 25 -21 -
EBIDTM -11% 12% 0% -28% 8% -20% 14% -13%
Other Income 54 676 -92% 56 352 -84% 58 71 -18% 148 64 130%
Interest 35 44 -20% 42 49 -15% 37 70 -48% 38 44 -13%
Depreciation 27 24 13% 25 6 282% 24 7 260% 24 7 241%
PBT 31 584 -95% -2 249 - 11 -40 - 21 -8 -
Tax 11 112 -90% -10 57 - -36 9 - 34 -1 -
PAT 20 472 -96% 8 192 -96% 46 -49 - -13 -6 -
PATM 20% 264% 3% 115% 27% -29% -7% -4%
EPS 0.26 6.25 -96% 0.11 2.55 -96% 0.61 -0.65 - -0.18 -0.08 -

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 606 1,138 -47% 1,113 1,184 -6% 1,169 1,103 6% 1,212 1,140 6%
Expenses 709 996 -29% 987 1,069 -8% 1,012 1,065 -5% 1,028 1,076 -4%
EBITDA -103 142 - 126 115 9% 157 38 313% 184 64 188%
EBIDTM -17% 12% 14% 10% 13% 3% 15% 6%
Other Income 4 20 -77% 18 10 84% 5 43 -89% 10 11 -8%
Interest 41 51 -19% 57 65 -12% 48 111 -57% 49 85 -42%
Depreciation 72 71 1% 80 60 34% 70 60 16% 71 56 27%
PBT -211 49 - 7 0 1527% 44 -218 - 127 -162 -
Tax -20 -26 - 50 183 -72% 117 -20 - 6 -15 -
PAT -191 75 - -43 -182 - -73 -197 - 121 -147 -
PATM -31% 7% 7% -15% -6% -18% 10% -13%
EPS -2.53 1.00 - -0.57 -2.41 - -0.97 -2.61 - 1.60 -1.95 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 624 702 656 659 645 612 611 369 353 281 265 Net Sales Growth -8% 7% 0% 2% 5% 0% 66% 5% 25% 6% Cost Of Goods Sold 597 147 132 136 151 147 147 108 101 79 71 Gross Profit 26 554 525 524 495 464 463 261 252 203 195 GP Margin 4% 79% 80% 79% 77% 76% 76% 71% 71% 72% 73% Total Expenditure 588 634 782 697 792 737 759 449 354 277 235 Power & Fuel Cost - 11 12 11 11 13 13 8 7 6 6 % Of Sales - 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% Employee Cost - 155 150 161 190 182 180 136 101 71 58 % Of Sales - 22% 23% 24% 29% 30% 29% 37% 29% 25% 22% Manufacturing Exp. - 237 311 302 294 296 287 91 67 53 43 % Of Sales - 34% 47% 46% 46% 48% 47% 25% 19% 19% 16% General & Admin Exp. - 79 131 75 66 110 113 94 66 61 52 % Of Sales - 11% 20% 11% 10% 18% 18% 25% 19% 22% 19% Selling & Distn. Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 3 46 13 82 9 39 12 11 7 0 % Of Sales - 0% 7% 2% 13% 2% 6% 3% 3% 3% 2% EBITDA 36 68 -125 -38 -147 -126 -149 -80 -1 5 30 EBITDA Margin 6% 10% -19% -6% -23% -21% -24% -22% 0% 2% 11% Other Income 316 938 524 138 169 185 218 230 191 127 176 Interest 152 160 192 64 106 65 81 91 134 103 54 Depreciation 100 97 27 29 27 25 27 17 23 12 10 PBT 61 749 180 8 -110 -31 -39 41 32 17 142 Tax 0 107 57 3 -39 -9 -2 17 15 0 0 Tax Rate 0% 17% 31% -6% 34% 19% 5% 42% 46% 0% 0% PAT 61 513 123 -64 -75 -40 -34 24 17 201 142 PAT before Minority Interest 61 513 123 -64 -75 -40 -34 24 17 201 142 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 10% 73% 19% -10% -12% -7% -6% 6% 5% 72% 53% PAT Growth -90% 317% 293% 15% -86% -19% -241% 39% -91% 42% EPS 0.81 6.80 1.63 -0.84 -0.99 -0.53 -0.45 0.32 0.23 2.67 1.88

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

624

702

656

659

645

612

611

369

353

281

265

Net Sales Growth

-8%

66%

25%

Cost Of Goods Sold

597

147

132

136

151

147

108

101

Gross Profit

554

525

524

495

464

463

261

252

203

195

GP Margin

79%

80%

79%

77%

76%

71%

72%

73%

Total Expenditure

588

634

782

697

792

737

759

449

354

277

235

Power & Fuel Cost

% Of Sales

Employee Cost

155

150

161

190

182

180

136

101

% Of Sales

22%

23%

24%

29%

30%

29%

37%

29%

25%

22%

Manufacturing Exp.

237

311

302

294

296

287

% Of Sales

34%

47%

46%

48%

47%

25%

19%

16%

General & Admin Exp.

131

110

113

% Of Sales

11%

20%

11%

10%

18%

25%

19%

22%

19%

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

13%

EBITDA

-125

-38

-147

-126

-149

-80

-1

EBITDA Margin

10%

-19%

-6%

-23%

-21%

-24%

-22%

11%

Other Income

316

938

524

138

169

185

218

230

191

127

176

Interest

152

160

192

106

134

103

Depreciation

100

PBT

749

180

-110

-31

-39

142

Tax

107

-39

-9

-2

Tax Rate

17%

31%

-6%

34%

19%

42%

46%

PAT

513

123

-64

-75

-40

-34

201

142

PAT before Minority Interest

513

123

-64

-75

-40

-34

201

142

Minority Interest

PAT Margin

10%

73%

19%

-10%

-12%

-7%

-6%

72%

53%

PAT Growth

-90%

317%

293%

15%

-86%

-19%

-241%

39%

-91%

42%

EPS

0.81

6.80

1.63

-0.84

-0.99

-0.53

-0.45

0.32

0.23

2.67

1.88

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 4,100 4,632 4,469 4,561 4,574 4,199 3,966 3,492 6,058 2,986 1,496 Net Sales Growth -10% 4% -2% 0% 9% 6% 14% -42% 103% 100% Cost Of Goods Sold 5,280 964 928 999 998 942 935 881 777 639 393 Gross Profit -1,180 3,668 3,541 3,562 3,576 3,257 3,031 2,611 5,281 2,347 1,103 GP Margin -29% 79% 79% 78% 78% 78% 76% 75% 87% 79% 74% Total Expenditure 3,736 4,023 4,244 4,288 4,221 3,995 3,835 3,440 5,405 2,581 1,436 Power & Fuel Cost - 104 100 95 101 108 103 94 87 69 42 % Of Sales - 2% 2% 2% 2% 3% 3% 3% 1% 2% 3% Employee Cost - 916 914 899 905 818 765 695 628 551 273 % Of Sales - 20% 20% 20% 20% 19% 19% 20% 10% 18% 18% Manufacturing Exp. - 1,405 1,537 1,588 1,663 1,620 1,475 1,236 892 668 390 % Of Sales - 30% 34% 35% 36% 39% 37% 35% 15% 22% 26% General & Admin Exp. - 542 627 514 474 482 481 406 385 322 277 % Of Sales - 12% 14% 11% 10% 11% 12% 12% 6% 11% 18% Selling & Distn. Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 92 142 195 84 47 106 127 2,637 333 0 % Of Sales - 2% 3% 4% 2% 1% 3% 4% 44% 11% 4% EBITDA 364 610 225 273 353 204 131 52 653 405 60 EBITDA Margin 9% 13% 5% 6% 8% 5% 3% 1% 11% 14% 4% Other Income 38 53 92 140 166 156 96 167 151 176 101 Interest 195 205 337 258 229 133 152 250 634 297 250 Depreciation 292 292 233 239 222 225 235 183 371 182 104 PBT -33 165 -252 -84 67 2 -160 -214 -200 101 -194 Tax 153 148 114 23 72 -8 5 11 231 41 15 Tax Rate -459% 65% -24% -2% 110% 20% -3% -5% 29% 38% 10% PAT -187 46 -663 -1,062 -64 -54 -178 -234 492 71 132 PAT before Minority Interest -198 79 -588 -988 -7 -31 -164 -229 564 67 136 Minority Interest -11 -34 -75 -75 -58 -23 -14 -5 -73 4 -4 PAT Margin -5% 1% -15% -23% -1% -1% -4% -7% 8% 2% 9% PAT Growth 0% 107% 38% -1,550% -19% 70% 24% -148% 594% -46% EPS -2.47 0.61 -8.79 -14.07 -0.85 -0.72 -2.36 -3.10 6.51 0.94 1.75

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

4,100

4,632

4,469

4,561

4,574

4,199

3,966

3,492

6,058

2,986

1,496

Net Sales Growth

-10%

-2%

14%

-42%

103%

100%

Cost Of Goods Sold

5,280

964

928

999

998

942

935

881

777

639

393

Gross Profit

-1,180

3,668

3,541

3,562

3,576

3,257

3,031

2,611

5,281

2,347

1,103

GP Margin

-29%

79%

78%

76%

75%

87%

79%

74%

Total Expenditure

3,736

4,023

4,244

4,288

4,221

3,995

3,835

3,440

5,405

2,581

1,436

Power & Fuel Cost

104

100

101

108

103

% Of Sales

Employee Cost

916

914

899

905

818

765

695

628

551

273

% Of Sales

20%

19%

20%

10%

18%

Manufacturing Exp.

1,405

1,537

1,588

1,663

1,620

1,475

1,236

892

668

390

% Of Sales

30%

34%

35%

36%

39%

37%

35%

15%

22%

26%

General & Admin Exp.

542

627

514

474

482

481

406

385

322

277

% Of Sales

12%

14%

11%

10%

11%

12%

11%

18%

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

142

195

106

127

2,637

333

% Of Sales

44%

11%

EBITDA

364

610

225

273

353

204

131

653

405

EBITDA Margin

13%

11%

14%

Other Income

140

166

156

167

151

176

101

Interest

195

205

337

258

229

133

152

250

634

297

250

Depreciation

292

233

239

222

225

235

183

371

182

104

PBT

-33

165

-252

-84

-160

-214

-200

101

-194

Tax

153

148

114

-8

231

Tax Rate

-459%

65%

-24%

-2%

110%

20%

-3%

-5%

29%

38%

10%

PAT

-187

-663

-1,062

-64

-54

-178

-234

492

132

PAT before Minority Interest

-198

-588

-988

-7

-31

-164

-229

564

136

Minority Interest

-11

-34

-75

-58

-23

-14

-5

-73

-4

PAT Margin

-5%

-15%

-23%

-1%

-4%

-7%

PAT Growth

107%

38%

-1,550%

-19%

70%

24%

-148%

594%

-46%

EPS

-2.47

0.61

-8.79

-14.07

-0.85

-0.72

-2.36

-3.10

6.51

0.94

1.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 8,876 8,363 4,227 4,272 3,747 3,680 3,710 3,205 3,205 3,019 Share Capital 755 755 519 518 463 463 463 410 410 409 Total Reserves 8,121 7,582 3,679 3,734 3,272 3,217 3,247 2,796 2,795 2,610 Non-Current Liabilities 1,288 346 179 126 622 632 1,293 720 761 481 Secured Loans 621 320 206 157 53 67 135 155 170 0 Unsecured Loans 0 0 26 26 584 530 1,117 543 509 446 Long Term Provisions 141 54 11 10 13 11 8 7 5 3 Current Liabilities 469 1,399 546 696 641 848 157 553 532 73 Trade Payables 212 196 146 140 114 97 51 47 46 28 Other Current Liabilities 158 89 192 101 93 738 97 198 59 42 Short Term Borrowings 84 1,101 194 442 422 0 0 301 423 0 Short Term Provisions 15 13 13 13 12 12 9 8 4 4 Total Liabilities 10,633 10,108 4,952 5,094 5,011 5,159 5,159 4,478 4,497 3,574 Net Block 906 180 203 186 172 190 146 118 85 74 Gross Block 1,097 279 285 234 195 301 268 225 172 151 Accumulated Depreciation 191 99 82 49 24 110 122 107 88 77 Non Current Assets 10,275 9,745 4,553 4,757 4,422 3,405 2,987 3,306 2,963 1,988 Capital Work in Progress 33 165 166 199 182 169 121 73 49 5 Non Current Investment 8,153 8,310 3,658 3,603 2,208 2,103 2,103 2,103 2,310 1,490 Long Term Loans & Adv. 1,181 1,081 513 759 1,458 886 593 839 503 403 Other Non Current Assets 2 9 13 10 401 57 24 174 17 16 Current Assets 359 364 399 337 589 1,755 2,172 1,172 1,534 1,586 Current Investments 0 0 0 0 220 308 692 303 0 41 Inventories 10 6 7 6 6 7 5 5 4 3 Sundry Debtors 81 84 71 76 102 95 87 93 62 54 Cash & Bank 4 33 89 6 9 6 26 109 15 38 Other Current Assets 263 206 83 151 252 1,338 1,361 662 1,453 1,449 Short Term Loans & Adv. 23 35 150 100 103 1,125 1,164 650 1,393 1,349 Net Current Assets -110 -1,035 -147 -358 -52 907 2,015 619 1,002 1,512 Total Assets 10,633 10,108 4,952 5,094 5,011 5,159 5,159 4,478 4,497 3,574

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

8,876

8,363

4,227

4,272

3,747

3,680

3,710

3,205

3,019

Share Capital

755

519

518

463

410

409

Total Reserves

8,121

7,582

3,679

3,734

3,272

3,217

3,247

2,796

2,795

2,610

Non-Current Liabilities

1,288

346

179

126

622

632

1,293

720

761

481

Secured Loans

621

320

206

157

135

155

170

Unsecured Loans

584

530

1,117

543

509

446

Long Term Provisions

141

Current Liabilities

469

1,399

546

696

641

848

157

553

532

Trade Payables

212

196

146

140

114

Other Current Liabilities

158

192

101

738

198

Short Term Borrowings

1,101

194

442

422

301

423

Short Term Provisions

Total Liabilities

10,633

10,108

4,952

5,094

5,011

5,159

4,478

4,497

3,574

Net Block

906

180

203

186

172

190

146

118

Gross Block

1,097

279

285

234

195

301

268

225

172

151

Accumulated Depreciation

191

110

122

107

Non Current Assets

10,275

9,745

4,553

4,757

4,422

3,405

2,987

3,306

2,963

1,988

Capital Work in Progress

165

166

199

182

169

121

Non Current Investment

8,153

8,310

3,658

3,603

2,208

2,103

2,310

1,490

Long Term Loans & Adv.

1,181

1,081

513

759

1,458

886

593

839

503

403

Other Non Current Assets

401

174

Current Assets

359

364

399

337

589

1,755

2,172

1,172

1,534

1,586

Current Investments

220

308

692

303

Inventories

Sundry Debtors

102

Cash & Bank

109

Other Current Assets

263

206

151

252

1,338

1,361

662

1,453

1,449

Short Term Loans & Adv.

150

100

103

1,125

1,164

650

1,393

1,349

Net Current Assets

-110

-1,035

-147

-358

-52

907

2,015

619

1,002

1,512

Total Assets

10,633

10,108

4,952

5,094

5,011

5,159

4,478

4,497

3,574

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 6,661 6,601 4,062 5,143 4,461 4,718 4,952 4,381 3,256 3,291 Share Capital 755 755 519 518 763 1,133 1,133 1,080 410 409 Total Reserves 5,902 5,822 3,515 4,608 3,690 3,585 3,820 3,301 2,847 2,879 Non-Current Liabilities 1,170 782 876 1,247 704 1,112 1,787 5,003 3,791 983 Secured Loans 953 636 477 795 273 473 533 2,213 1,459 478 Unsecured Loans 1 1 472 484 594 532 1,126 2,604 2,214 456 Long Term Provisions 76 66 64 55 43 47 44 41 32 18 Current Liabilities 2,579 3,591 2,134 1,926 1,450 1,602 972 3,108 4,499 455 Trade Payables 598 754 763 589 561 529 482 879 756 169 Other Current Liabilities 1,537 1,522 850 577 322 983 412 1,768 848 219 Short Term Borrowings 363 1,231 452 680 512 27 32 346 2,836 51 Short Term Provisions 82 85 69 80 56 63 46 115 59 16 Total Liabilities 10,955 11,486 8,327 9,484 7,007 7,585 7,851 13,514 12,378 4,759 Net Block 8,802 8,477 4,992 5,419 3,642 4,218 4,147 9,274 9,180 2,524 Gross Block 9,946 9,384 5,642 5,865 3,871 5,390 5,152 10,297 10,142 3,016 Accumulated Depreciation 1,144 907 646 446 229 1,173 1,006 1,023 962 492 Non Current Assets 10,014 9,819 7,045 7,709 5,592 5,947 5,810 10,958 10,466 3,363 Capital Work in Progress 204 450 226 268 226 228 147 244 566 258 Non Current Investment 175 190 1,397 1,486 883 848 824 798 235 36 Long Term Loans & Adv. 703 597 382 481 496 638 684 574 437 543 Other Non Current Assets 131 105 48 54 346 15 8 68 48 2 Current Assets 940 1,667 1,282 1,775 1,415 1,636 2,040 2,556 1,912 1,397 Current Investments 0 79 335 392 569 616 993 389 6 62 Inventories 78 57 67 62 60 64 62 92 80 26 Sundry Debtors 459 542 470 473 444 409 441 663 546 194 Cash & Bank 266 856 220 546 167 190 259 512 415 163 Other Current Assets 138 152 185 145 174 358 286 899 865 951 Short Term Loans & Adv. -16 -20 5 157 89 269 223 821 755 919 Net Current Assets -1,638 -1,924 -853 -152 -36 34 1,069 -552 -2,587 942 Total Assets 10,955 11,486 8,327 9,484 7,007 7,585 7,851 13,514 12,378 4,759

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

6,661

6,601

4,062

5,143

4,461

4,718

4,952

4,381

3,256

3,291

Share Capital

755

519

518

763

1,133

1,080

410

409

Total Reserves

5,902

5,822

3,515

4,608

3,690

3,585

3,820

3,301

2,847

2,879

Non-Current Liabilities

1,170

782

876

1,247

704

1,112

1,787

5,003

3,791

983

Secured Loans

953

636

477

795

273

473

533

2,213

1,459

478

Unsecured Loans

472

484

594

532

1,126

2,604

2,214

456

Long Term Provisions

Current Liabilities

2,579

3,591

2,134

1,926

1,450

1,602

972

3,108

4,499

455

Trade Payables

598

754

763

589

561

529

482

879

756

169

Other Current Liabilities

1,537

1,522

850

577

322

983

412

1,768

848

219

Short Term Borrowings

363

1,231

452

680

512

346

2,836

Short Term Provisions

115

Total Liabilities

10,955

11,486

8,327

9,484

7,007

7,585

7,851

13,514

12,378

4,759

Net Block

8,802

8,477

4,992

5,419

3,642

4,218

4,147

9,274

9,180

2,524

Gross Block

9,946

9,384

5,642

5,865

3,871

5,390

5,152

10,297

10,142

3,016

Accumulated Depreciation

1,144

907

646

446

229

1,173

1,006

1,023

962

492

Non Current Assets

10,014

9,819

7,045

7,709

5,592

5,947

5,810

10,958

10,466

3,363

Capital Work in Progress

204

450

226

268

226

228

147

244

566

258

Non Current Investment

175

190

1,397

1,486

883

848

824

798

235

Long Term Loans & Adv.

703

597

382

481

496

638

684

574

437

543

Other Non Current Assets

131

105

346

Current Assets

940

1,667

1,282

1,775

1,415

1,636

2,040

2,556

1,912

1,397

Current Investments

335

392

569

616

993

389

Inventories

Sundry Debtors

459

542

470

473

444

409

441

663

546

194

Cash & Bank

266

856

220

546

167

190

259

512

415

163

Other Current Assets

138

152

185

145

174

358

286

899

865

951

Short Term Loans & Adv.

-16

-20

157

269

223

821

755

919

Net Current Assets

-1,638

-1,924

-853

-152

-36

1,069

-552

-2,587

942

Total Assets

10,955

11,486

8,327

9,484

7,007

7,585

7,851

13,514

12,378

4,759

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 100 -61 -15 22 -761 -144 -45 1 100 0 PBT 621 180 -60 -114 -50 -39 41 32 201 142 Adjustment -553 -288 44 -15 -36 -76 -71 -28 -19 -111 Changes in Working Capital 44 99 -1 111 -656 1 14 24 -44 -11 Cash after chg. in Working capital 111 -10 -17 -19 -742 -113 -16 27 139 19 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -11 -52 2 40 -19 -31 -29 -26 -38 -19 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity 810 -4,688 245 -72 394 294 -522 312 -723 -436 Net Fixed Assets -686 8 -18 -56 92 -80 -92 -77 -65 -15 Net Investments 157 -4,652 -55 -1,174 -17 384 -389 -96 -779 -135 Others 1,339 -43 318 1,158 319 -10 -41 485 121 -286 Cash from Financing Activity -972 4,792 -292 45 370 -170 484 -219 599 469 Net Cash Inflow / Outflow -62 43 -62 -5 3 -20 -83 95 -23 32 Opening Cash & Equivalents -19 -62 0 5 6 26 108 14 36 4 Closing Cash & Equivalent -80 -19 -62 0 9 6 26 108 14 36

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

100

-61

-15

-761

-144

-45

100

PBT

621

180

-60

-114

-50

-39

201

142

Adjustment

-553

-288

-15

-36

-76

-71

-28

-19

-111

Changes in Working Capital

-1

111

-656

-44

-11

Cash after chg. in Working capital

111

-10

-17

-19

-742

-113

-16

139

Interest Paid

Tax Paid

-11

-52

-19

-31

-29

-26

-38

-19

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

810

-4,688

245

-72

394

294

-522

312

-723

-436

Net Fixed Assets

-686

-18

-56

-80

-92

-77

-65

-15

Net Investments

157

-4,652

-55

-1,174

-17

384

-389

-96

-779

-135

Others

1,339

-43

318

1,158

319

-10

-41

485

121

-286

Cash from Financing Activity

-972

4,792

-292

370

-170

484

-219

599

469

Net Cash Inflow / Outflow

-62

-5

-20

-83

-23

Opening Cash & Equivalents

-19

-62

108

Closing Cash & Equivalent

-80

-19

-62

108

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 172 -179 493 966 195 24 479 1,644 298 -82 PBT 239 -110 -912 552 34 -137 149 731 113 -206 Adjustment 418 427 1,372 342 249 309 455 938 346 233 Changes in Working Capital -146 -247 53 184 44 -28 -20 224 -54 -34 Cash after chg. in Working capital 511 69 513 1,078 327 143 584 1,893 405 -7 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -339 -248 -20 -111 -132 -119 -105 -250 -107 -75 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity 60 -3,323 -335 -1,002 113 213 2,669 -1,003 -910 2,178 Net Fixed Assets -686 8 -18 -56 92 -80 -92 -77 -65 -15 Net Investments 157 -4,652 -55 -1,174 -17 384 -389 -96 -779 -135 Others 589 1,322 -262 229 38 -91 3,150 -830 -65 2,328 Cash from Financing Activity -862 4,257 -672 259 -354 -304 -3,217 -74 691 -3,240 Net Cash Inflow / Outflow -630 755 -515 224 -47 -67 -69 567 79 -1,144 Opening Cash & Equivalents 634 -165 348 123 179 249 485 405 161 1,305 Closing Cash & Equivalent 7 634 -165 348 142 183 249 485 405 161

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

172

-179

493

966

195

479

1,644

298

-82

PBT

239

-110

-912

552

-137

149

731

113

-206

Adjustment

418

427

1,372

342

249

309

455

938

346

233

Changes in Working Capital

-146

-247

184

-28

-20

224

-54

-34

Cash after chg. in Working capital

511

513

1,078

327

143

584

1,893

405

-7

Interest Paid

Tax Paid

-339

-248

-20

-111

-132

-119

-105

-250

-107

-75

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-3,323

-335

-1,002

113

213

2,669

-1,003

-910

2,178

Net Fixed Assets

-686

-18

-56

-80

-92

-77

-65

-15

Net Investments

157

-4,652

-55

-1,174

-17

384

-389

-96

-779

-135

Others

589

1,322

-262

229

-91

3,150

-830

-65

2,328

Cash from Financing Activity

-862

4,257

-672

259

-354

-304

-3,217

-74

691

-3,240

Net Cash Inflow / Outflow

-630

755

-515

224

-47

-67

-69

567

-1,144

Opening Cash & Equivalents

634

-165

348

123

179

249

485

405

161

1,305

Closing Cash & Equivalent

634

-165

348

142

183

249

485

405

161

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 118 110 81 82 81 80 80 79 79 74 ROA 5% 2% -1% -1% -1% -1% 0% 0% 5% 4% ROE 6% 2% -2% -2% -1% -1% 1% 1% 6% 6% ROCE 8% 5% 0% 0% 0% 1% 3% 4% 8% 6% Fixed Asset Turnover 1.02 2.33 2.54 3.00 2.47 2.15 1.50 1.78 1.74 1.82 Receivable days 43 43 41 50 59 55 89 80 76 71 Inventory Days 4 4 3 3 4 4 5 5 5 4 Payable days 114 97 81 69 58 41 49 57 61 56 Cash Conversion Cycle -67 -51 -37 -15 5 17 45 29 19 19 Total Debt/Equity 0.08 0.17 0.13 0.15 0.29 0.34 0.34 0.32 0.35 0.15 Interest Cover 5 2 0 0 0 1 1 1 3 4

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

118

110

ROA

-1%

ROE

-2%

-1%

ROCE

Fixed Asset Turnover

1.02

2.33

2.54

3.00

2.47

2.15

1.50

1.78

1.74

1.82

Receivable days

Inventory Days

Payable days

114

Cash Conversion Cycle

-67

-51

-37

-15

Total Debt/Equity

0.08

0.17

0.13

0.15

0.29

0.34

0.32

0.35

0.15

Interest Cover

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 88 87 78 99 90 87 93 91 72 72 ROA 1% -6% -11% 0% 0% -2% -2% 4% 1% 2% ROE 1% -11% -22% 0% -1% -4% -6% 17% 2% 6% ROCE 5% -2% -11% 4% 2% 0% 0% 14% 6% 7% Fixed Asset Turnover 0.48 0.59 0.79 0.94 0.91 0.75 0.45 0.59 0.45 0.54 Receivable days 39 41 38 37 37 39 58 36 45 43 Inventory Days 5 5 5 5 5 6 8 5 6 6 Payable days 66 74 64 54 53 52 80 108 80 55 Cash Conversion Cycle -22 -28 -21 -12 -11 -7 -14 -66 -28 -6 Total Debt/Equity 0.20 0.30 0.49 0.43 0.34 0.38 0.38 1.48 2.36 0.37 Interest Cover 2 0 -3 1 1 0 0 2 1 2

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

-6%

-11%

-2%

ROE

-11%

-22%

-1%

-4%

-6%

17%

ROCE

-2%

-11%

14%

Fixed Asset Turnover

0.48

0.59

0.79

0.94

0.91

0.75

0.45

0.59

0.45

0.54

Receivable days

Inventory Days

Payable days

108

Cash Conversion Cycle

-22

-28

-21

-12

-11

-7

-14

-66

-28

-6

Total Debt/Equity

0.20

0.30

0.49

0.43

0.34

0.38

1.48

2.36

0.37

Interest Cover

-3

Fortis Healthcare Ltd.

Hospital & Healthcare Services

BSE: 532843 | NSE: FORTIS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Fortis Healthcare Ltd.

Hospital & Healthcare Services

BSE: 532843 | NSE: FORTIS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update